19.08.2019 • NewsElaine BurridgeElkem

Elkem Buys South Korea’s Basel Chemie

Elkem Buys South Korea’s Basel Chemie
Elkem Buys South Korea’s Basel Chemie

Norwegian silicon producer Elkem is buying Basel Chemie, a South Korean producer of specialty silicon gels, for $26.9 million. Elkem said the deal gives it access to leading technology in attractive end-user silicon segments and a solid platform for further development and growth.

Basel Chemie manufactures silicon for use in skin care and cosmetics applications and in water repellents for the construction industry. It has a manufacturing plant near Gunsan and a R&D center and offices in Seoul. The company employs 32 people and had a turnover of $7.7 million in 2018.

“This acquisition strengthens our position in downstream specialized silicones. Basel Chemie complements our market offering and brings additional technologies to our specialty portfolio in Asia where we have strong positions in other segments,” said Elkem’s CEO Helge Aasen.

The acquisition is expected to close by the end of September, subject to regulatory approvals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.